Navigation Links
Venture-backed companies drive job creation, even in tough times

MADISON During last springs legislative debate on the pros and cons of a major venture capital bill, it was sadly apparent that more than a few Wisconsin lawmakers had their doubts about the merits of non-traditional investment capital.

The next time this debate rolls around, lets hope members of the Senate and Assembly have read the latest study of venture capitals role in the growing U......

Full article >>> TomoTherapys equipment is designed to target radiation treatment to the patient's tumor while helping to limit damage as much as possible to the surrounding tissues. It allows for better patient planning, more accurate delivery of radiotherapy, better dosage control, and fewer side effects.

In 2003, TomoTherapy sales were about $15 million. This year, sales could reach $40 million and ne......

Full article >>>
'"/> By Tom Still 07/26/04

Related biology technology :

1. Venture-backed firms could become eligible for federal SBIR grants
2. A disgusting video: U.S. companies sell out Americans
3. Pre-eminent, web-based companies owe success to corporate venturing
4. Visions: IT exec says CIOs must be ready to help companies ramp up trade
5. Patent licensing: For enforcing companies, the rules have changed
6. Madison firm provides $200K in capital to tech companies
7. Gala Biotech among companies sold for $3.3 billion
8. 2006: A mixed blessing for Midwest life science companies
9. Weather information companies launch data product
10. New firm to help companies land federal dollars
11. Wisconsin companies reach deal on electronic health records
Post Your Comments:

(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... is exhibiting at the Pennsylvania Convention Center and will showcase its product’s latest ... ClinCapture will also be presenting a scientific poster on Disrupting Clinical Trials in ...
(Date:6/23/2016)... India , June 23, 2016 ... media market research report to its pharmaceuticals section ... profiles, product details and much more. ... spread across 151 pages, profiling 15 companies and ... available at . ...
Breaking Biology Technology:
(Date:4/28/2016)... India , April 28, 2016 ... Infosys (NYSE: INFY ), and Samsung SDS, a ... that will provide end customers with a more secure, ... services.      (Logo: ) , ... services, but it also plays a fundamental part in enabling ...
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
Breaking Biology News(10 mins):